Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24